The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
At this year’s 2024 Community Oncology Conference we will have 50+ speakers and co-chairs touching on subjects like practice perspectives on the Enhancing Oncology Model, increased attention on PBM misbehavior, employer-driven care, and much more.
Our Dynamic Keynote Speaker
Our Dynamic Keynote Speaker
KEY NOTE SPEAKER NAME
THURSDAY, APRIL 4, 2024 AT 9:40 AM EDT
Info on the key note
Conference Speakers
Judith Alberto, MHA, RPh, BCOP
Community Oncology Alliance
Judith Alberto, MHA, RPh, BCOP
About the Speaker
Judy Alberto, MHA, RPh, BCOP is Director of Clinical Initiatives at the Community Oncology Alliance (COA), the nation’s only non-profit organization dedicated to preserving and protecting local, affordable, and accessible cancer care. In this role, she supports and promotes the success of community oncology practices participating in clinical and payment reform initiatives.
Working closely with COA’s quality and value team, Alberto seeks to support the design, awareness, and participation in oncology payment and delivery reform initiatives. This includes oncology models from the Centers for Medicare & Medicaid Services, as well as participants in the National Cancer Treatment Alliance, a COA-led clinically integrated network engaging directly with employers and payers. Alberto also helps lead the Community Oncology Pharmacy Association (COPA), an 875+ strong peer-to-peer network of medically integrated pharmacies located in independent community oncology and urology practices across the country.
Prior to joining COA, Judy was the director of oncology and investigational drug services pharmacy at the Sidney Kimmel Cancer Center – Jefferson Health. She joined Jefferson in 2010, working her way up from patient care pharmacist to her directorship. Prior to joining Jefferson, she worked as a pharmacist at Express Scripts in Bensalem, PA, and the University of Pennsylvania Health System.
Judy received her pharmacy degree from the Philadelphia College of Pharmacy and Science and a Master of Healthcare Administration from the University of Arizona.
Thursday, March 23rd; 11:00 – 11:45 AM
Practice Perspectives: The Enhancing Oncology Model & Commercial Payment Reform Initiatives, Moderator
Miriam Atkins, MD, FACP
AO Multispecialty Clinic, Community Oncology Alliance
Miriam Atkins, MD, FACP
About the Speaker
Dr. Atkins earned a Bachelor of Arts in Biology from Hampton University, Hampton, VA and her Doctor of Medicine from Eastern Virginia Medical School, Norfolk, VA. She completed her Residency in Internal Medicine (1993) and her Fellowship in Hematology/Oncology (1996) at Brooke Army Medical Center, Fort Sam Houston, San Antonio, TX. While serving in the Army, she attained the rank of Major. Dr. Atkins worked at Texas Oncology for two years prior to moving to Augusta, GA. She joined, Augusta Oncology, the only privately-owned Oncology practice in the Augusta, GA area in 2000. She is board certified in Medical Oncology.
Dr. Atkins is the Associate Medical Director for Pruitt Hospice, Assistant Clinical Professor for the American University of Antigua and the University of Medicine and Health Sciences in St. Kitts. She holds leadership positions at the hospitals in Augusta, GA. Dr. Atkins is the Vice President of the Medical Executive Committee at University Hospital and the former chairperson of the Credentials Committee for University HealthLink. She is a member of the Cancer Committee at Doctors Hospital and University Hospital.
Dr. Atkins has been an active member of the Community Oncology Alliance since its inception. She is currently the CPAN Medical Co-chair and the Secretary of the organization.
In her spare time, Dr. Atkins enjoys traveling and competitive Ballroom Dancing.
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology
Robert Baird, Jr., RN, MSA
National Cancer Treatment Alliance
Robert Baird, Jr., RN, MSA
About the Speaker
Robert has extensive experience in healthcare management developing strategic plans and directing financial, operational and clinical initiatives. He is currently the President of the National Cancer Treatment Alliance (NCTA) positioning community oncology practices for success across the Nation in the changing health care environment. Prior to joining NCTA Robert was the CEO of Dayton Physicians, where he merged 3 independent Physician practices (Medical Oncology/Radiation Oncology/Urology) to create a large multi-specialty practice. He expanded the network from 2 locations to 6 comprehensive centers, 18 to over 40 Providers and generated over $170 million in annual revenues. Robert received his Master of Science in Hospital and Health Service Administration from Central Michigan University, a Bachelor of Science in Education from Bowling Green State University and a Nursing Degree from Excelsior College.
Thursday, March 23rd; 9:05 – 9:55 AM
The New Horizon: Working Directly with Employers, Moderator
Glenn Balasky
Rocky Mountain Cancer Center
Glenn Balasky
About the Speaker
In May of 2014, Glenn Balasky joined Rocky Mountain Cancer Centers (RMCC) as the Executive Director for this progressive 55 physician multi-specialty oncology group. He has over 21 years of experience in oncology practice operations and management and has been involved in healthcare for his entire career.
Prior to joining RMCC his most recent positions included a Director of Marketing position at Cardinal Health and 10 years as Executive Director at The Zangmeister Center in Columbus, OH. There he helped another leading oncology group build a stand-alone cancer center putting a broad variety of cancer services under one roof for the first time in central Ohio.
Glenn has experience in several areas of oncology practice management including electronic medical records, pharmacy, and practice operations. He has made presentations at several national meetings on the business of oncology and has been to Washington D.C. numerous times to work with congressional representatives on cancer related issues.
Glenn is like all of us and has seen family members and friends pass away due to cancer. His commitment to making cancer care better at RMCC comes through his ability to identify complex problems and find solutions to solve the problems. He believes that everyone is an important part of the team at RMCC and has an equally important role in helping patients through their healthcare journey.
He is a graduate of the University of Michigan with a bachelor’s degree in Microbiology. Outside of work he enjoys running, cycling, and skiing and is very proud of the accomplishments of his wife and his two adult children.
Thursday, March 23rd; 2:25 – 3:20 PM
Survive & Prosper: Optimizing Revenue & Increasing Efficiency in Your Practice
Conference Co-Chairs
Moshe C. Chasky, MD, FACP
Alliance Cancer Specialists
Moshe C. Chasky, MD, FACP
About the Speaker
Dr. Chasky is a physician specializing in Hematology and Medical Oncology. He is a partner at the largest community oncology practice in the greater Philadelphia area and serves on the Board of Directors. He completed a fellowship at Fox Chase Cancer Center in 2008. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Chasky is the Chair of the Clinical Practice Committee at the American Society of Clinical Oncology and the current president of the Pennsylvania Society of Oncology and Hematology. He serves on the Board of Directors of Community Oncology Alliance. Previously, Dr. Chasky served as president of Lower Merion Synagogue in his community from 2020 through 2022.
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Stephen “Fred” Divers, MD
About the Co-Chair
Dr. Divers received his medical degree from Louisiana State University where he was a selected as a member of Alpha Omega Alpha. He completed his residency in Internal Medicine at the University of North Carolina at Chapel Hill. During his tenure there, he was named the Outstanding Resident all three years and received the Chairman’s award for his performance in medicine. He completed a dual fellowship in Hematology and Oncology at University of Alabama, where he conducted clinical trials in combined modality therapy for lung cancer and translational research with gene arrays and immune checkpoint therapy. He was honored as the Outstanding Clinical Fellow and Outstanding Research Fellow while in Alabama. Following completion of his training, he joined Genesis Cancer Center in Hot Springs, Arkansas in 2004 as a practicing physician. Locally, he served as Chief of Staff for CHI ST Vincent hospital and Chairman of the Cancer committee. He was instrumental in founding the CPAN chapter for patient advocacy in in Arkansas. He has continued clinical research in the private setting, publishing data from multiple trials involved with cell free DNA sequencing and therapeutics. He continues to serve as a member of the ION advisory panel and on the Community Oncology Alliance as an active board member and Co-Chair for the annual conference. He and his partners joined American Oncology Network in 2018 with a group from Louisiana as the founding practices. He is currently Chairman of the Advisory board for AON, and remains passionate about the success of community oncology.
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 3:50 – 4:35 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice, Moderator
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
Kathy Oubre
Pontchartrain Cancer Center
Kathy Oubre
About the Co-Chair
Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana.
Kathy is a board member of the Community Oncology Alliance and co-chairs the Biosimilars committee and serves on their Government Affairs committee. Kathy chairs the NCODA Oncology Institute. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health. Kathy is a member of ACCC and serves on their Oral Oncolytics Advisory committee. She is a member of the national MGMA and serves on their government affairs group. She is also the past president for the Louisiana MGMA and chairs their government affairs committee. Kathy also serves on the editorial boards for The Center for Biosimilars and Evidence-Based Oncology.
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Alti Rahman MHA, MBA, CSSBB
About the Co-Chair
Alti is the Practice Administrator for Oncology Consultants. He holds a dual Masters degree in Healthcare and Business Administration from the University of Houston and is a Certified Six Sigma Black Belt (CSSBB).
Oncology Consultant’s has 14 Medical Oncology offices. Ancillary services include 2 Radiation Oncology office, 2 Diagnostic Imaging centers, 3 Retail Pharmacy’s, and Clinical Research programs all supported by a central administrative office.
Alti holds additional roles including: Six Sigma course instructor for Medical Group Management Association (MGMA), Board Member of COA (Community Oncology Alliance) and Co-Chair of the COA Administrator Network (CAN), Treasurer for the National Cancer Care Alliance (NCCA), Steering Committee Member for McKesson Specialty Health, Board Member of the Oncology Circle Advisory, and President of the Coalition of Hematology and Oncology Practices (CHOP).
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 4:40 – 5:25 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
Stephen Schleicher, MD, MBA
Tennessee Oncology
Stephen Schleicher, MD, MBA
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Stephen Schleicher, MD, MBA, was appointed Chief Medical Officer (CMO) of Tennessee Oncology, one of the largest providers of oncology care in the country and the largest in Tennessee, in January 2022. In that role, Dr. Schleicher oversees clinical programs to promote the high-quality, innovative and patient-centered care Tennessee Oncology is known for delivering throughout Tennessee and North Georgia. Prior to this, Stephen served as Medical Director of Value-Based Care across both Tennessee Oncology and OneOncology, a national platform for independent community oncology practices that now includes over 700 oncology providers across the US. Dr. Schleicher received his medical training from Harvard’s Brigham and Women’s Hospital and Memorial Sloan Kettering (MSK) in New York before returning to his hometown of Nashville to join Tennessee Oncology. Dr. Schleicher also spent time as a consultant at McKinsey and Company and received his MBA from Harvard Business School. In addition to his role as CMO for Tennessee Oncology, Dr. Schleicher serves as President of the Tennessee Oncology Practice Society.
Emily Touloukian, DO
Coastal Cancer Center
Emily Touloukian, DO
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 11:50 AM – 12:35 PM
What Every Practice Needs to Know: The NEW Value-Based Enterprise
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
About
